Straipsniai su viešo pasiekiamumo įpareigojimais - L. Jeffrey MedeirosSužinokite daugiau
Niekur nepasiekiama: 25
MYC translocation in chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosis
YO Huh, KIC Lin, F Vega, E Schlette, CC Yin, MJ Keating, R Luthra, ...
British journal of haematology 142 (1), 36-44, 2008
Įpareigojimai: US National Institutes of Health
Prognostic factors of hepatosplenic T-cell lymphoma: clinicopathologic study of 28 cases
M Yabe, LJ Medeiros, G Tang, SA Wang, S Ahmed, Y Nieto, S Hu, ...
The American journal of surgical pathology 40 (5), 676-688, 2016
Įpareigojimai: US National Institutes of Health
Characteristics and treatment of advanced breast implant–associated anaplastic large cell lymphoma
MS Collins, RN Miranda, LJ Medeiros, MPS de Meneses, SP Iyer, ...
Plastic and reconstructive surgery 143 (3S), 41S-50S, 2019
Įpareigojimai: US National Institutes of Health
Pediatric therapy-related myelodysplastic syndrome/acute myeloid leukemia: the MD Anderson Cancer Center experience
DG Aguilera, C Vaklavas, AM Tsimberidou, S Wen, LJ Medeiros, ...
Journal of Pediatric Hematology/Oncology 31 (11), 803-811, 2009
Įpareigojimai: US National Institutes of Health
Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphoma
R Tao, PK Allen, A Rodriguez, F Shihadeh, CC Pinnix, I Arzu, VK Reed, ...
International Journal of Radiation Oncology* Biology* Physics 92 (1), 122-129, 2015
Įpareigojimai: US National Institutes of Health
Clinicopathologic features and outcomes of lymphoplasmacytic lymphoma patients with monoclonal IgG or IgA paraprotein expression
X Cao, LJ Medeiros, Y Xia, X Wang, SK Thomas, S Loghavi, X Li, JJ Shah, ...
Leukemia & Lymphoma 57 (5), 1104-1113, 2016
Įpareigojimai: US National Institutes of Health
Immune checkpoint blockade: releasing the brake towards hematological malignancies
Y Xia, LJ Medeiros, KH Young
Blood reviews 30 (3), 189-200, 2016
Įpareigojimai: US National Institutes of Health
Clinical implications of positron emission tomography-negative residual computed tomography masses after chemotherapy for diffuse large B-cell lymphoma
BS Dabaja, J Phan, O Mawlawi, LJ Medeiros, C Etzel, FW Liang, ...
Leukemia & lymphoma 54 (12), 2631-2638, 2013
Įpareigojimai: US National Institutes of Health
De Novo MYC and BCL2 Double-hit B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) in Pediatric and Young Adult Patients Associated With Poor …
W Liu, S Hu, M Konopleva, JD Khoury, N Kalhor, G Tang, ...
Pediatric hematology and oncology 32 (8), 535-547, 2015
Įpareigojimai: National Natural Science Foundation of China
Primary bone lymphoma exhibits a favorable prognosis and distinct gene expression signatures resembling diffuse large B-cell lymphoma derived from centrocytes in the germinal …
X Li, ZY Xu-Monette, S Yi, BS Dabaja, GC Manyam, J Westin, N Fowler, ...
The American journal of surgical pathology 41 (10), 1309-1321, 2017
Įpareigojimai: US National Institutes of Health
Association of gene mutations with time‐to‐first treatment in 384 treatment‐naive chronic lymphocytic leukaemia patients
B Hu, KP Patel, HC Chen, X Wang, R Luthra, MJ Routbort, ...
British journal of haematology 187 (3), 307-318, 2019
Įpareigojimai: US National Institutes of Health
Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1
S Loghavi, N Pemmaraju, R Kanagal-Shamanna, M Mehrotra, ...
Blood, The Journal of the American Society of Hematology 125 (21), 3360-3363, 2015
Įpareigojimai: US National Institutes of Health
Routine sequencing in CLL has prognostic implications and provides new insight into pathogenesis and targeted treatments
B Hu, KP Patel, HC Chen, X Wang, F Wang, R Luthra, MJ Routbort, ...
British Journal of Haematology 185 (5), 852-864, 2019
Įpareigojimai: US National Institutes of Health
Clinical experience with the heat shock protein-90 inhibitor, tanespimycin, in patients with relapsed lymphoma
Y Oki, A Copeland, J Romaguera, L Fayad, M Fanale, SC Faria, ...
Leukemia & lymphoma 53 (5), 990-992, 2012
Įpareigojimai: US National Institutes of Health
T (6; 14)(q25; q32) involves BCL11B and is highly associated with mixed-phenotype acute leukemia, T/myeloid
W Wang, H Beird, CJ Kroll, S Hu, CE Bueso-Ramos, H Fang, G Tang, ...
Leukemia 34 (9), 2509-2512, 2020
Įpareigojimai: Cancer Prevention Research Institute of Texas, USA
The B cell antigen receptor in atypical chronic lymphocytic leukemia with t (14; 19)(q32; q13) demonstrates remarkable stereotypy
CD Schweighofer, YO Huh, R Luthra, RL Sargent, RP Ketterling, ...
International journal of cancer 128 (11), 2759-2764, 2011
Įpareigojimai: US National Institutes of Health
Primary breast diffuse large B-cell lymphoma: treatment strategies and patterns of failure
EB Ludmir, SA Milgrom, CC Pinnix, JR Gunther, J Westin, Y Oki, LE Fayad, ...
Leukemia & lymphoma 59 (12), 2896-2903, 2018
Įpareigojimai: US National Institutes of Health
Radiation therapy for salivary gland MALT lymphoma: ultra-low dose treatment achieves encouraging early outcomes and spares salivary function
JR Gunther, C Park, BS Dabaja, SA Milgrom, RJ Cruz Chamorro, ...
Leukemia & lymphoma 61 (1), 171-175, 2020
Įpareigojimai: US National Institutes of Health
High expression of human homologue of murine double minute 4 and the short splicing variant, HDM4-S, in bone marrow in patients with acute myeloid leukemia or myelodysplastic …
X Han, LJ Medeiros, YH Zhang, MJ You, M Andreeff, M Konopleva, ...
Clinical Lymphoma Myeloma and Leukemia 16, S30-S38, 2016
Įpareigojimai: US National Institutes of Health
CXC chemokine receptor 4 expression, CXC chemokine receptor 4 activation, and wild-type nucleophosmin are independently associated with unfavorable prognosis in patients with …
S Konoplev, P Lin, CC Yin, E Lin, GMN González, HM Kantarjian, ...
Clinical Lymphoma Myeloma and Leukemia 13 (6), 686-692, 2013
Įpareigojimai: US National Institutes of Health
Leidyklos ir finansavimo informaciją automatiškai nustato kompiuterio programa